A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI)

A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI) AbbreviationsALBAlbuminALTAlanine aminotransferaseAPRIaspartate aminotransferase/platelet count ratio indexAPTTActivated partial prothrombin timeASTAspertate aminotransferaseAUCareas under the ROCAvailability of data and materialNot applicablecDFClassic dengue feverConsent for publicationNot applicableDFdengue feverDSSdengue shock syndromeDHFdengue hemorrhagic feverEthics statementNot applicablePLTplatelet countPTProthrombin timeROCReceiver Operating Characteristic CurveSDDsevere dengue diseasesSesensitivitySpspecificityTPTotal proteinWBCLeukocyte countINTRODUCTIONWith an estimated 390 million cases in over 100 countries and regions in Asia, Oceania, the Americas, and Africa, dengue fever (DF) is now among the most important vector‐borne diseases worldwide. Both the incidence and number of epidemic areas have increased significantly in recent years, particularly in Southeast Asia, the Pacific, and the Americas, making DF a major emerging infectious disease. DF presents with a wide clinical spectrum, ranging from a self‐limiting infection (85‐90% of cases) to severe dengue diseases (SDD), which occurs in approximately 5% of cases, and includes both dengue shock syndrome (DSS) and dengue hemorrhagic fever (DHF). There is no effective vaccine for the prevention of dengue infection, nor are there any antiviral agents or immune modulators that can reduce its mortality. However, with good supportive medical care, mortality rates of less than 1% can be achieved, even with the inclusion of DSS cases. Therefore, diagnostic indicators are important to ensure early SDD recognition. Published studies have reported http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Virology Wiley

A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI)

Loading next page...
 
/lp/wiley/a-novel-predictor-of-severe-dengue-the-aspartate-aminotransferase-2UgFe8Bd30
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
0146-6615
eISSN
1096-9071
D.O.I.
10.1002/jmv.25021
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsALBAlbuminALTAlanine aminotransferaseAPRIaspartate aminotransferase/platelet count ratio indexAPTTActivated partial prothrombin timeASTAspertate aminotransferaseAUCareas under the ROCAvailability of data and materialNot applicablecDFClassic dengue feverConsent for publicationNot applicableDFdengue feverDSSdengue shock syndromeDHFdengue hemorrhagic feverEthics statementNot applicablePLTplatelet countPTProthrombin timeROCReceiver Operating Characteristic CurveSDDsevere dengue diseasesSesensitivitySpspecificityTPTotal proteinWBCLeukocyte countINTRODUCTIONWith an estimated 390 million cases in over 100 countries and regions in Asia, Oceania, the Americas, and Africa, dengue fever (DF) is now among the most important vector‐borne diseases worldwide. Both the incidence and number of epidemic areas have increased significantly in recent years, particularly in Southeast Asia, the Pacific, and the Americas, making DF a major emerging infectious disease. DF presents with a wide clinical spectrum, ranging from a self‐limiting infection (85‐90% of cases) to severe dengue diseases (SDD), which occurs in approximately 5% of cases, and includes both dengue shock syndrome (DSS) and dengue hemorrhagic fever (DHF). There is no effective vaccine for the prevention of dengue infection, nor are there any antiviral agents or immune modulators that can reduce its mortality. However, with good supportive medical care, mortality rates of less than 1% can be achieved, even with the inclusion of DSS cases. Therefore, diagnostic indicators are important to ensure early SDD recognition. Published studies have reported

Journal

Journal of Medical VirologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off